ScholarIQanswers from OpenAlex

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways

PaperCitations, authors & open-access status

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways have?

ScholarIQcitation count

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways has 409 citations in the OpenAlex counts ScholarIQ stores.

When was Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways published?

ScholarIQyear

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways has 2014 year in the ScholarIQ index.

What is the open-access status of Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways?

ScholarIQoa status

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways has bronze oa status in the ScholarIQ index.

What is the DOI of Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways?

ScholarIQdoi

The DOI for Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways is on the source record.

What is the PMID of Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways?

ScholarIQpmid

The PMID for Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways is on the source record.

What is the OpenAlex record for Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways?

ScholarIQopenalex

The OpenAlex for Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial